The short version
- Why people research itMitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- What the evidence isThe human record is Soviet and post-Soviet clinical work — real patients and real endpoints, published in Russian and rarely replicated to Western standards.
- What to watchStomach pain that wakes you or does not settle.
How Chonluten works
Chonluten is Glu-Asp-Gly: 3 residues, formula C11H17N3O8, average mass 319.28 Da. It is the smallest molecule on any Khavinson page on this site, and two things follow from that size which nobody selling it mentions.
It is Epitalon with the first residue removed. Epitalon is Ala-Glu-Asp-Gly. Take the N-terminal alanine off and what is left is Glu-Asp-Gly, exactly 71.08 Da lighter.
- Injectable
On the goal map: Liver, kidney, gut & lung (Organ-specific bioregulation)
Research on Chonluten5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
The human record is Soviet and post-Soviet clinical work — real patients and real endpoints, published in Russian and rarely replicated to Western standards.
Correlative data
Used for bronchial and gastric mucosal support — an unusual pairing that comes from the tissue it was isolated alongside rather than from a shared mechanism anyone has demonstrated.
How the mechanism reads
Glu-Asp-Gly — a synthetic tripeptide proposed to support mucosal tissue protein synthesis in the airway and stomach lining.
MechanisticThe shared claim across the Khavinson series: peptides this short are proposed to enter the cell nucleus and bind promoter regions of DNA, shifting tissue-specific gene expression.
MechanisticMucosal epithelium turns over fast, which cuts both ways: rapid renewal is where a gene-expression effect should show up soonest, and also where spontaneous improvement is most likely to be mistaken for one.
Mechanistic
Sources
- Avolio F, et al. (co-authors include Khavinson VKh). Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line. International Journal of Molecular Sciences 2022;23(7):3607 · PMID 35408963
- Fedoreyeva LI, et al. Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA. Biochemistry (Moscow) 2011;76(11):1210–1219 · PMID 22117547
- Khavinson VKh, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. Molecules 2021;26(22):7053 · PMID 34834147
- Kolchina N, Khavinson V, Linkova N, Yakimov A, Baitin D, Afanasyeva A, Petukhov M. Systematic search for structural motifs of peptide binding to double-stranded DNA. Nucleic Acids Research 2019;47(20):10553–10563 · PMID 31598715
- Khavinson V, Linkova N, Kozhevnikova E, Dyatlova A, Petukhov M. Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. International Journal of Molecular Sciences 2022;23(14):7733 · PMID 35887081
- Khavinson VK, Linkova NS, Rudskoy AI, Petukhov MG. Feasibility of Transport of 26 Biologically Active Ultrashort Peptides via LAT and PEPT Family Transporters. Biomolecules 2023;13(3):552 · PMID 36979488
- Kuzubova NA, Lebedeva ES, Dvorakovskaya IV, Surkova EA, Platonova IS, Titova ON. Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial Epithelium in Rats with Obstructive Lung Pathology. Bulletin of Experimental Biology and Medicine 2015;159(5):685–688 · PMID 26468022
- Alsulaimani RA, Quinn TJ (independent — not the Khavinson group). The efficacy and safety of animal-derived nootropics in cognitive disorders: Systematic review and meta-analysis. Cerebral Circulation – Cognition and Behavior 2021;2:100012 · PMID 36324709
Chonluten safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Black stool, vomiting blood or unexplained weight loss with stomach pain.
- New indigestion after age 50 that has not been checked.
- Untreated Helicobacter pylori, since it is a curable cause of the symptom.
- Pregnancy or breastfeeding, where mucosal growth peptides have no safety data.
What’s expected
- Nothing immediate; the claim is support of bronchial and gastric mucosal protein synthesis.
- Possible easing of mild reflux-type discomfort, uncontrolled.
- Little human data.
Watch for
- Stomach pain that wakes you or does not settle.
- Black tar-like stool.
- Difficulty swallowing.
Labs that tell you it’s working
- Ferritin: falling iron stores are the quiet sign of stomach bleeding.
- Complete Blood Count: a falling hemoglobin with small red cells points to slow blood loss.
- Vitamin B12: gastric lining damage shows up as poor absorption.
Respiratory and gastric mucosa peptide bioregulator; its main risk is delaying the diagnosis of curable stomach disease. PMID 35408963
Bloodwork to runHow you would know it is working: 8 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Chonluten FAQ4 common questions
- Is Chonluten approved for human use?
- No. Chonluten is a research compound.
- What is Chonluten researched for?
- Mitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- Which labs show whether it's doing anything?
- Ferritin; Complete Blood Count; Vitamin B12: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Chonluten: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



